1. Home
  2. ILMN vs PHM Comparison

ILMN vs PHM Comparison

Compare ILMN & PHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • PHM
  • Stock Information
  • Founded
  • ILMN 1998
  • PHM 1950
  • Country
  • ILMN United States
  • PHM United States
  • Employees
  • ILMN N/A
  • PHM N/A
  • Industry
  • ILMN Medical Specialities
  • PHM Homebuilding
  • Sector
  • ILMN Health Care
  • PHM Consumer Discretionary
  • Exchange
  • ILMN Nasdaq
  • PHM Nasdaq
  • Market Cap
  • ILMN 22.9B
  • PHM 27.2B
  • IPO Year
  • ILMN 2000
  • PHM N/A
  • Fundamental
  • Price
  • ILMN $147.53
  • PHM $128.52
  • Analyst Decision
  • ILMN Buy
  • PHM Buy
  • Analyst Count
  • ILMN 20
  • PHM 16
  • Target Price
  • ILMN $160.68
  • PHM $145.00
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • PHM 1.5M
  • Earning Date
  • ILMN 11-04-2024
  • PHM 01-30-2025
  • Dividend Yield
  • ILMN N/A
  • PHM 0.62%
  • EPS Growth
  • ILMN N/A
  • PHM 10.14
  • EPS
  • ILMN N/A
  • PHM 13.56
  • Revenue
  • ILMN $4,390,000,000.00
  • PHM $17,318,808,000.00
  • Revenue This Year
  • ILMN N/A
  • PHM $11.29
  • Revenue Next Year
  • ILMN $4.28
  • PHM $4.29
  • P/E Ratio
  • ILMN N/A
  • PHM $9.47
  • Revenue Growth
  • ILMN N/A
  • PHM 2.80
  • 52 Week Low
  • ILMN $97.36
  • PHM $95.36
  • 52 Week High
  • ILMN $156.66
  • PHM $149.47
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 56.64
  • PHM 43.16
  • Support Level
  • ILMN $138.88
  • PHM $125.37
  • Resistance Level
  • ILMN $144.00
  • PHM $130.73
  • Average True Range (ATR)
  • ILMN 4.84
  • PHM 3.27
  • MACD
  • ILMN 0.36
  • PHM -0.30
  • Stochastic Oscillator
  • ILMN 88.42
  • PHM 22.60

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About PHM PulteGroup Inc.

PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes, and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.

Share on Social Networks: